4//SEC Filing
Bagarazzi Mark 4
Accession 0001055726-18-000011
CIK 0001055726other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 6:40 PM ET
Size
14.3 KB
Accession
0001055726-18-000011
Insider Transaction Report
Form 4
Bagarazzi Mark
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2018-03-09$4.51/sh−6,896$31,101→ 66,732 total - Exercise/Conversion
Common Stock
2018-03-10+20,434→ 87,166 total - Exercise/Conversion
Common Stock
2018-03-09+25,000→ 73,628 total - Exercise/Conversion
Restricted Stock Unit
2018-03-09−25,000→ 25,000 total→ Common Stock (25,000 underlying) - Tax Payment
Common Stock
2018-03-10$4.51/sh−5,653$25,495→ 81,513 total - Exercise/Conversion
Restricted Stock Unit
2018-03-10−20,434→ 40,866 total→ Common Stock (20,434 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 75,000 restricted stock units is as follows: 25,000 shares vested on March 9, 2017; 25,000 shares vested on March 9, 2018; 25,000 shares will vest on March 9, 2019. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.
- [F2]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.
- [F3]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 61,300 restricted stock units is as follows: 20,434 shares vested on March 10, 2018; 20,433 shares will vest on March 10, 2019; 20,433 shares will vest on March 10, 2020. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.
- [F4]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (3) herein.
Documents
Issuer
INOVIO PHARMACEUTICALS, INC.
CIK 0001055726
Entity typeother
Related Parties
1- filerCIK 0001539067
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 6:40 PM ET
- Size
- 14.3 KB